Dyadic International, Inc. (NASDAQ:DYAI) Q2 2024 Earnings Call Transcript
Dyadic International, Inc. (NASDAQ:DYAI) Q2 2024 Earnings Call Transcript August 13, 2024Dyadic International, Inc. reports earnings inline with expectations.
Dyadic International Inc (DYAI)
Market is closed
News
- 1 - 10
- Next >>
Dyadic International, Inc. (NASDAQ:DYAI) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, good evening, and welcome to Dyadic International's Q1 2024 Conference Call. Currently, all participants are in a listen-only mode.
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript
Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07.
Dyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcript
Operator: Good evening, and welcome to the Dyadic International's Third Quarter 2023 Financial Results Conference Call. Currently all participants are in a listen-only mode.
Dyadic International, Inc. (NASDAQ:DYAI) Q2 2023 Earnings Call Transcript
Operator: Good evening, and welcome to Dyadic International's Second Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Dyadic International, Inc. (NASDAQ:DYAI) Q1 2023 Earnings Call Transcript
Operator: Good evening, and welcome to Dyadic International's First Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2022 Earnings Call Transcript
Operator: Good evening, and welcome to Dyadic International's Fiscal Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Is DYAI Stock A Buy Here?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
10 Best Biotech Stocks Under $6 in 2021
In this article we will take a look at the 10 best biotech stocks under $6 in 2021.
5 Best Biotech Stocks Under $6 in 2021
Seelos Therapeutics, Inc. (NASDAQ: SEEL) is a New York-based biotech firm that develops and sells drugs related to treatment of the central nervous system, respiratory, and other disorders.
- 1 - 10
- Next >>
Billionaire Hedge Funds
